SCHEMBL6539090

SCHEMBL6539090

COc1ccc(-c2nc(C(F)F)oc2-c2ccc(OCCNS(C)(=O)=O)cc2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
HDAC6 Q9UBN7 10/20 0.38
DYRK3 O43781 1/20 0.38
ROCK2 O75116 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
CDK1 P06493 1/20 0.38
ROS1 P08922 1/20 0.38
PIM1 P11309 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38
AKT1 P31749 1/20 0.38
CLK2 P49760 1/20 0.38
GSK3B P49841 1/20 0.38
IRAK1 P51617 1/20 0.38
RPS6KA3 P51812 1/20 0.38
PRKX P51817 1/20 0.38
CDK5 Q00535 1/20 0.38
PRKCD Q05655 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540567 0.92 ALDH1A1 (0.39) ALDH1A1DYRK3ROCK2PRKD3MAP4K4
SCHEMBL6539135 0.87 PPARD (0.39) HDAC6PPARDMEN1KMT2AHDAC4
SCHEMBL6207411 0.85 PPARD (0.41) ALDH1A1HDAC6DYRK3ROCK2PRKD3
SCHEMBL6234392 0.84 PPARD (0.41) ALDH1A1HDAC6CDK2GSK3BMKNK2
SCHEMBL6538917 0.84 PPARD (0.42) HDAC6MKNK2PPARDMEN1KMT2A
SCHEMBL6234081 0.83 PPARD (0.39) HDAC6MKNK2PPARDMEN1KMT2A
SCHEMBL6540528 0.83 ALDH1A1 (0.38) ALDH1A1DYRK3ROCK2PRKD3MAP4K4
SCHEMBL6540113 0.83 TP53 (0.39) ALDH1A1DYRK3ROCK2PRKD3MAP4K4
SCHEMBL6539836 0.82 RCE1 (0.43) HDAC6MKNK2PPARDMEN1KMT2A
SCHEMBL6540424 0.81 ALDH1A1 (0.42) ALDH1A1DYRK3ROCK2PRKD3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 ALDH1A1 163/4885HDAC6 1851/4885DYRK3 4350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.